SCHEMBL2507288

SCHEMBL2507288

CCCCN1Cc2cc(N(C)c3cnccc3Nc3ccccc3)ccc2C1=O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 2/20 0.38
KDM4C Q9H3R0 9/20 0.37
KDM6B O15054 7/20 0.37
IDH1 O75874 1/20 0.37
PTGS1 P23219 1/20 0.35
PTGS2 P35354 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPK1 P28482 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
EGFR P00533 1/20 0.35
SRC P12931 1/20 0.35
CCNB2 O95067 1/20 0.34
CCNE2 O96020 1/20 0.34
CDK1 P06493 1/20 0.34
FGFR1 P11362 1/20 0.34
CDK4 P11802 1/20 0.34
CCNB1 P14635 1/20 0.34
CCNA2 P20248 1/20 0.34
FGFR2 P21802 1/20 0.34
FGFR4 P22455 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2509717 0.88 KDM4C (0.38) GRM5KDM4CKDM6BIDH1PTGS1
SCHEMBL2514237 0.85 GRM5 (0.40) GRM5KDM4CKDM6BIDH1ALDH1A1
SCHEMBL2511391 0.82 GRM5 (0.38) GRM5KDM4CIDH1PTGS1PTGS2
SCHEMBL2511387 0.82 PRF1 (0.36) GRM5KDM4CKDM6BIDH1ALDH1A1
SCHEMBL2511617 0.80 PRF1 (0.37) GRM5KDM4CKDM6BIDH1ALDH1A1
SCHEMBL2507290 0.80 HDAC6 (0.39) GRM5KDM4CKDM6BIDH1PTGS1
SCHEMBL2503427 0.77 HDAC6 (0.43) GRM5KDM4CKDM6BIDH1ALDH1A1
SCHEMBL2512031 0.77 PRF1 (0.38) GRM5ALDH1A1GRM1PRF1
SCHEMBL2506683 0.76 GRM5 (0.41) GRM5IDH1ALDH1A1GRM1PRF1
SCHEMBL2509716 0.72 KDM4E (0.38) GRM5KDM4CKDM6BIDH1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8664214-B2 Small molecule potentiators of metabotropic glutamate receptors I AbbVie Deutschland GmbH & Co. KG (DE) 2014-03-04 US claimed
US-8664214-B2 Small molecule potentiators of metabotropic glutamate receptors I AbbVie Deutschland GmbH & Co. KG (DE) 2014-03-04 US disclosed
US-20110245232-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS I ABBOTT GMBH & CO. KG (DE) 2011-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110245232-A1 NOVEL SMALL MOLECULE POTENTIATORS OF METABOTROPIC GLUTAMATE RECEPTORS I GRM3, GRIN2C, GRIN2B GRM5 17/4885KDM4C 2588/4885KDM6B 3609/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.